Effect of TEAS (Transcutaneous Electrical Acupoint Stimulation) on Postoperative Pain in Patients after Gastrectomy: An Open Randomized Controlled Trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022692

Enrollment

Unknown

Registered

2019-04-22

Start date

2019-05-01

Completion date

Unknown

Last updated

2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

TEAS Group:Transcutaneous Electrical Acupoint Stimulation (TEAS)

Control Group:Sham Stimulation

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Regardless of gender or ethnicity; 2. Aged 18 to 75 years; 3. Scheduled for laparoscopic radical gastrectomy; 4. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Received neoadjuvant therapy; 2. American Society of Anesthesiologists class more than 3; 3. TNM stage IV; 4. Preoperative severe electrolytic disturbance; 5. Having or had diabetes mellitus; 6. Body Mass Index (BMI)32 kg/m2; 7. Deformity of limbs or local skin infection; 8. Active systemic infections or infectious diseases; 9. Chronic constipation or diarrhea; 10. Having or had cardiocerebrovascular accidents or central nervous system injury; 11. Received analgesic therapy in the past month; 12. Mentally incapacity or significant emotional or psychiatric disorder; 13. Cardiac pacemaker; 14. Pregnant; Gastrointestinal obstruction, perforation, bleeding and other emergencies; 15. Gastrointestinal obstruction, perforation, bleeding and other emergencies; 16. Perioperative risk of bleeding or use of anticoagulants; 17. Currently received therapy about acupoints; 18. Transferred to other department after surgery; 19. Varicose veins of lower extremities; 20. Involvement in other clinical trials; 21. Anesthesia mode was not iv plus epidural.

Design outcomes

Primary

Measure	Time frame
Pain Scores;Usage of Analgesics;	—

Secondary

Measure	Time frame
First flatus time after operation;First defecation time after operation;Frequency of nausea after operation;Frequency of vomiting after operation;Frequency of distention after operation;Frequency of diarrhea after operation;Comfort score of fluid diet (12h after eating);WBC count;NEU proportion;Hemoglobin Concentration;CRP Concentration;PCT Concentration;TNF-a Concentration;IL-2 Concentration;IL-6 Concentration;IL-10 Concentration;IL-12 Concentration;ß-endorphin Concentration;Total bilirubin;Albumin;Prealbumin;Cholesterol;Triglyceride;HDL;LDL;LP(a);Fasting blood glucose;Mg;Ca;Na;Ka;	—

Measure

Time frame

First flatus time after operation;First defecation time after operation;Frequency of nausea after operation;Frequency of vomiting after operation;Frequency of distention after operation;Frequency of diarrhea after operation;Comfort score of fluid diet (12h after eating);WBC count;NEU proportion;Hemoglobin Concentration;CRP Concentration;PCT Concentration;TNF-a Concentration;IL-2 Concentration;IL-6 Concentration;IL-10 Concentration;IL-12 Concentration;ß-endorphin Concentration;Total bilirubin;Albumin;Prealbumin;Cholesterol;Triglyceride;HDL;LDL;LP(a);Fasting blood glucose;Mg;Ca;Na;Ka;

—

Countries

China

Contacts

Public ContactYanbing Zhou

Affiliated Hospital of Qingdao University

zhouyanbing999@aliyun.com+86 13708971773

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026